Cite
HARVARD Citation
Lontos, K. et al. (2022). A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Leukemia & lymphoma. 63 (13), pp. 3257-3260. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lontos, K. et al. (2022). A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Leukemia & lymphoma. 63 (13), pp. 3257-3260. [Online].